New York’s cannabis industry was supposed to be different. Built on promises of equity, community reinvestment, and opportunity for those harmed most by prohibition, it sounded like a reset. A clean slate.
But let’s be honest—what’s actually unfolding looks a lot more like a familiar story: big money moves in fast, and the people who built the culture are left fighting for space.
This is where Cannabis Multi-State Operators (MSOs) come in—and why their role in New York deserves a real conversation.
The Rise of MSOs: Big Money, Bigger Problems
MSOs are large cannabis companies operating across multiple legal states. On paper, they bring capital, infrastructure, and “professionalism.” In reality, their model is showing cracks—and fast.
1. The Debt Problem Nobody Wants to Talk About
Many MSOs expanded aggressively, grabbing licenses and building facilities in as many states as possible. That growth came at a cost.
We’re talking billions in debt—much of it coming due by 2026. That pressure forces companies into survival mode: layoffs, market exits, and in some cases, bankruptcy.
Growth at all costs sounds great in a pitch deck. It doesn’t work as well in a heavily regulated, federally illegal industry.
2. The 280E Tax Trap
Here’s the kicker: cannabis businesses can’t deduct normal operating expenses because of federal law.
That means MSOs—and every legal operator—can face tax rates pushing 70–80%.
For smaller businesses, it’s brutal. For massive corporations with bloated overhead, it’s a slow bleed that turns revenue into illusion instead of profit.
3. No Real “Scale” in Cannabis
In most industries, bigger means more efficient. Not here.
Because cannabis can’t legally cross state lines, MSOs are forced to recreate the same operation in every state:
grow facility, processing, distribution, retail—over and over again.
That’s not scale. That’s duplication.
And it leads to inconsistent products, operational chaos, and brands that feel completely different depending on where you buy them.
4. Product Quality Takes a Back Seat
Let’s just say it plainly—corporate cannabis often prioritizes yield over quality.
When production targets, investor expectations, and quarterly numbers take priority, things like terpene preservation, curing time, and cultivar integrity get pushed aside.
The result? Cannabis that looks good on paper but lacks the experience people actually want.
This is where the disconnect really shows. Cannabis isn’t just a product—it’s culture, craft, and connection. And you can’t mass-produce that without losing something.
The Impact on New York’s Local Market
New York was meant to uplift small growers, legacy operators, and communities impacted by prohibition. But MSOs are already influencing the landscape in ways that raise serious concerns.
Crowding Out the Little Guy
With deeper pockets and stronger political influence, large companies are often better positioned to secure licenses, real estate, and supply chain advantages.
Meanwhile, small growers—especially those from legacy backgrounds—face high barriers to entry, limited access to capital, and a system that’s slower to support them than promised.
Profits Leaving the State
When a large, out-of-state company operates in New York, where do the profits go?
Not back into Buffalo. Not into local communities. Not into the people who helped build cannabis culture here.
They go back to corporate headquarters.
That’s not community reinvestment. That’s extraction.
Social Equity… on Paper vs Reality
New York’s cannabis rollout emphasized social equity. But critics argue that some MSOs have taken advantage of that system through predatory partnerships and financing deals.
Ownership on paper doesn’t always mean real control or long-term wealth for equity applicants.
And that’s a problem.
Legacy Market vs Legal Market: What Actually Changed?
Let’s talk about the elephant in the room.
The legacy market didn’t disappear—it adapted.
What Changed:
- Legal access expanded
- Testing and regulation increased safety (in theory)
- Branding and retail experiences became more polished
- Tax revenue started flowing to the state
What Didn’t:
- Price gaps still drive consumers to the legacy market
- Quality is often still better in small-batch, legacy-grown cannabis
- Community trust still leans toward local growers
- Barriers to entry still keep many legacy operators out of the legal system
In many ways, the legal market didn’t replace the legacy market—it just layered over it.
Why Small Growers Matter More Than Ever
This is where things get real.
Small growers aren’t just part of the industry—they are the foundation of it.
They:
- Preserve unique genetics and cultivars
- Prioritize quality over mass production
- Stay connected to their communities
- Reinvent cultivation techniques with care and intention
They don’t answer to shareholders. They answer to the plant—and the people.
And in a state like New York, especially in places like Buffalo, that local connection matters.
The Future: A Necessary Shakeout
The cannabis industry is entering a correction phase. Some MSOs are restructuring, downsizing, or disappearing entirely.
Investors are more cautious. Consumers are more educated. And the hype is wearing off.
What’s left?
The businesses that actually make sense:
- Sustainable operations
- Quality-focused cultivation
- Strong community ties
In other words—the exact things small growers have been doing all along.
Final Thoughts: Where You Spend Your Money Matters
This isn’t about hating big business. It’s about understanding impact.
Every purchase is a decision:
- Support local or support corporate
- Invest in craft or settle for mass production
- Build community or fund extraction
At Her Seed Bank, we believe in genetics, education, and empowering growers—especially here in Buffalo, New York and across the broader cannabis community.
Because the future of cannabis shouldn’t be controlled by who has the most money.
It should be shaped by the people who care about the plant the most.
Follow Here for more info and updates